Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Huadong Medicine Co Ltd A (000963 CH)
Watchlist
61
Analysis
Health Care
•
China
Huadong Medicine Co., Ltd. wholesales and retails medicines, pharmaceutical preparations, biological products, and medical instruments. Through its subsidiaries, the Company also manufactures antibiotic medicines and biochemical products.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Bloomage Biotechnology Lt
•
11 Jan 2022 09:17
Bloomage Biotechnology (688363.CH) Vs Imeik Technology (300896.CH) - The Logic and the Outlook
This insight compare the two leading companies in China medical beauty industry Bloomage and Imeik in terms of the difference in positioning,...
Xinyao (Criss) Wang
Follow
583 Views
Share
bearish
•
Hansoh Pharmaceutical
•
13 Dec 2021 09:11
Hansoh Pharmaceutical (3692.HK) - Lackluster Pipeline, so Bet on SiRNA?
This article mainly analyzed Hansoh Pharmaceutical in terms of the business, the key products, the pipeline, the concerns, the insights on...
Xinyao (Criss) Wang
Follow
438 Views
Share
bullish
•
Imeik Technology Development C
•
06 Sep 2021 09:14
Pre-IPO Imeik Technology Development (300896 CH) - Is High Profitability Sustainable?
The article analyzed Imeik in terms of the medical aesthetic industry characteristics, the business, the financial position and the concerns on...
Xinyao (Criss) Wang
Follow
535 Views
Share
bearish
•
Imeik Technology Development C
•
19 Jul 2021 09:30
Imeik Technology Development (300896.CH) - The Valuation Bubble?
This insight mainly analyzed Imeik in terms of its hyaluronic acid product business, botulinum toxin business, other products, the future business...
Xinyao (Criss) Wang
Follow
516 Views
Share
bearish
•
Kweichow Moutai
•
07 Oct 2019 14:43
Shanghai/​​Shenzhen Connect Ideas: Stalled Flows Ahead of Golden Week (2019-10-04)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
Ke Yan, CFA, FRM
Follow
653 Views
Share
First
Previous
8
9
10
11
12
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x